B Doped Zn Single‐Atom Nanozyme With Enhanced Oxidase‐Like Activity Combined CRISPR/Cas13a System for RNA Sensing

Abstract Single‐atom nanozyme (SAZ) with peroxidase‐like activity has attracted great attention in point‐of‐care (POC) diagnostic, but the use of unstable H 2 O 2 in peroxidase catalytic reactions often leads to low detection accuracy. Thus, developing SAZ with high oxidase (OD)‐like activity to construct RNA sensing systems independent of H 2 O 2 is imperative for improving accuracy. Herein, a novel strategy to fabricate boron‐nitrogen co‐doped zinc SAZ (ZnBNC‐SAZ) with excellent OD‐like activity by carbonizing Zn based zeolitic boron imidazolate frameworks is reported. The electron deficient B in imidazolate ligand can form Zn─N─B bond in situ during high temperature pyrolysis, which can regulate the electronic structure of Zn and further upshift the d‐band center of Zn to improve the OD‐like activity. With ZnBNC‐SAZ as signal generator, a new method for sensitive RNA detection is developed by combining CRISPR/ cas13 system with terminal deoxynucleotidyl transferase‐induced DNA extension reaction. The limits of detection for RNAs are as low as 20 aM. The proposed biosensor is adaptable to a lateral‐flow‐based readout and is universally applicable for sensing various RNAs by programming the guide RNA. Importantly, the proposed biosensor can monitor the cellular differentiation and identify patients with cervical carcinoma, showing great potential for application in facile POC diagnosis.